| Inflammatory Bowel Disease |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Remission |
0 |
0.67 |
| Immunization |
0 |
0.5 |
| Ulcerative Colitis |
0 |
0.39 |
| Colitis |
0 |
0.33 |
| A-Scan Biometry |
0 |
0.25 |
| Biosimilars |
0 |
0.25 |
| Scan |
0 |
0.25 |
| Care and Maintenance of Vision |
0 |
0.21 |
| Cataract |
0 |
0.21 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.08 |
| Brachial |
0 |
0.08 |
| Endoscopy |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.08 |
| Id Reaction |
0 |
0.08 |
| Immunocompromise |
0 |
0.08 |
| Immunomodulator |
0 |
0.08 |
| Rectal Hemorrhage |
0 |
0.08 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.08 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Dermatitis |
0 |
0.07 |
| Vaccines |
0 |
0.07 |